Mayne Pharma Group Limited (ASX:MYX) Updates on Scheme of Arrangement with Cosette
Mayne Pharma (ASX:MYX) updates investors on its Scheme of Arrangement with Cosette, addressing recent regulatory and contractual developments.
Mayne Pharma (ASX:MYX) updates investors on its Scheme of Arrangement with Cosette, addressing recent regulatory and contractual developments.
Elph Investments increases its takeover offer for Engenco Limited (ASX:EGN) from $0.305 to $0.31 per share.
Noxopharm Limited (ASX:NOX) receives ethics approval for its innovative HERACLES clinical trial, advancing new treatments for chronic inflammatory diseases.
St Barbara Limited (ASX:SBM) confirms a 3 Mtpa processing hub at 15-Mile, ensuring robust gold production and strong project economics.
Avecho Biotechnology Limited (ASX:AVE) receives $1.66M under the R&D Tax Incentive to support its Phase III insomnia trial and commercialization efforts.
TerraCom Limited (ASX:TER) has settled ASIC whistleblower proceedings with a $7.5 million penalty, pending court approval.
Recce Pharmaceuticals (ASX:RCE) secures a China Patent for its RECCE® anti-infectives, enhancing its global intellectual property portfolio.
Victory Metals Limited (ASX:VTM) addresses ASX’s query on significant trading activity and confirms compliance with listing rules.
Dimerix (ASX:DXB) successfully completes IDMC review of ACTION3 Phase 3 trial, affirming DMX-200’s safety profile.
Dexus (ASX:DXS) secures an injunction against APAC, safeguarding shareholder rights until an August court ruling.